{"SPADE_UN_09879": {"Clinical Information": [], "Patent Information": [{"Patent No": "US 4795740 A", "Patent Link": "http://www.lens.org/lens/patent/US_4795740_A", "Patent Type": "Granted Patent", "Publication Date": "1989-1-3", "Family Info": "Unknown", "Patent Title": "Antiviral peptides and means for treating herpes infections.", "Abstract": "Disclosed herein are antiviral peptides of the formula A-R.sup.8 -R.sup.9 -R.sup.10 -R.sup.11 -R.sup.12 -R.sup.13 -R.sup.14 -R.sup.15 -B wherein A is from zero up to seven amino acid residues and includes a terminal hydrogen or a terminal N-acyl, or A is a phenylacetyl with optional substitution of the para position of the phenyl, R.sup.8, R.sup.9, R.sup.10, R.sup.13, R.sup.14 and R.sup.15 are various amino acid residues with the stipulation that one or more of the four amino acid residues immediately preceding R.sup.11 may optionally be deleted, R.sup.11 and R.sup.12 are independently Val, D-Val, Nva, D-Nva, Leu, D-Leu, Nle, D-Nle, Ile or D-Ile, and B is hydroxy, amino or lower alkylamino. The antiviral activity of the peptides can be enhanced by combining them with a protease inhibitor. The peptides and the combination are useful for the treatment of herpes viral infections in mammals."}], "Sequence Information": {"SPADE ID": "SPADE_UN_09879", "Sequence": "ECRSTSYAGAVVNDL", "Sequence Length": 15, "Peptide Name": "Sequence 1 from Patent US 4795740", "Source": "Synthetic construct", "Biological Activity": ["Antimicrobial", "Antiviral"], "Frequent Amino Acids": "ASV", "Absent Amino Acids": "FHIKMOPQUW", "Basic Residues": 1, "Acidic Residues": 2, "Hydrophobic Residues": 6, "Polar Residues": 11, "Positive Residues": 1, "Negative Residues": 2, "Mass": 1584.71, "PI": 4.37, "Net Charge": -1, "Hydrophobicity": -0.05, "Similar Sequences": [{"SPADE_ID": "SPADE_UN_09880", "Similarity": 1.0, "Sequence": "STSYAGAVVNDL"}, {"SPADE_ID": "SPADE_UN_14937", "Similarity": 1.0, "Sequence": "YAGAVVNDL"}, {"SPADE_ID": "SPADE_UN_14945", "Similarity": 1.0, "Sequence": "YAGAVVNDL"}]}}}